MedPath

Bariatric Subfertility Trial

Conditions
SubfertilityPCOSMorbid obesityBariatric surgeryLife style modification
Registration Number
NL-OMON29279
Lead Sponsor
J.S.E. Laven, MD, PhDErasmus Medical CenterDepartment of Department of Reproductive Endocrinology3000 CA Rotterdam, The Netherlands
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
240
Inclusion Criteria

•Age 18-40 years

•BMI > 35 kg/m2.

Exclusion Criteria

•Azoospermia, endometriosis AFS class > III, WHO class III anovulation (premature ovarian failure) or endocrinopathies (such as Cushing syndrome, adrenal hyperplasia and diabetes type I).

•Pregnancy induced hypertension, preeclampsia, eclampsia or HELPP syndrome in a previous pregnancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint is the rate of healthy born baby rate after at least 37 weeks of gestation (primary end point) within three years after therapy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath